Skip to main content

Breadcrumb

  1. Home

Population: Community, County or City

Lower-Extremity Amputation among Patients with Diabetes Rate (PQI 16)

Admissions for any-listed diagnosis of diabetes and any-listed procedure of lower-extremity amputation (except toe amputations) per 100,000 population, ages 18 years and older. Excludes any-listed diagnosis of traumatic lower-extremity amputation admissions, obstetric admissions, and transfers from other institutions.

[NOTE: The software provides the rate per population. However, common practice reports the measure as per 100,000 population. The user must multiply the rate obtained from the software by 100,000 to report admissions per 100,000 population.]

CBE ID
0285

Methotrexate: CBC within 12 weeks

This measure identifies adult patients with rheumatoid arthritis who were prescribed at least a 6-month supply of methotrexate during the measurement year and received a CBC test within 120 days (3 months + 1 month grace period) following the earliest observed methotrexate prescription claim

CBE ID
0598

Methotrexate: Creatinine within 12 weeks

This measure identifies adult patients with rheumatoid arthritis who were prescribed at least a 6-month supply of methotrexate during the measurement year and received a serum creatinine test in the 120 days (3 months + 1 month grace period) after the earliest observed methotrexate prescription claim.

CBE ID
0599

Methotrexate: LFT within 12 weeks

This measure identifies adult patients with rheumatoid arthritis who were prescribed at least a 6-month supply of methotrexate during the measurement year and received a liver function test (LFT) in the 120 days (3 months + 1 month grace period) following the earliest observed methotrexate prescription claim.

CBE ID
0597

MI - Use of Beta Blocker Therapy

The percentage of patients aged 18 years and older diagnosed with myocardial infarction (MI) who are taking a beta blocker

CBE ID
0613e

New Atrial Fibrillation: Thyroid Function Test

This measure identifies patients with new-onset atrial fibrillation during the measurement year who have had a thyroid function test 6 weeks before or after the diagnosis of atrial fibrillation.

CBE ID
0600

New Rheumatoid Arthritis Baseline ESR or CRP within Three Months

This measure identifies adult patients newly diagnosed with rheumatoid arthritis during the first 8 months of the measurement year who received erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) lab tests either 4 months (3 months + 1-month grace period) before or after the initial diagnosis.

CBE ID
0601

Pancreatic Resection Volume (IQI 2)

The number of hospital discharges with a procedure of partial or total pancreatic resection for patients 18 years and older or obstetric patients. Excludes acute pancreatitis admissions.

CBE ID
0366